A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Zhijie,Xu ^[1] ; Hemant,Gujar ^[2] ; Guanghou,Fu ^[2] ; Hamed,Ahmadi ^[1] ; Sumeet,Bhanvadia ^[2] ; Daniel J,Weisenberger ^[2] ; Baiye,Jin ^[2] ; Parkash S,Gill ^[3] ; Inderbir,Gill ^[1] ; Siamak,Daneshmand ^[4] ; Kimberly D,Siegmund ^[2] ; Gangning,Liang ^[2]

作者单位： Department of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. ^[1] USC Institute of Urology and Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. ^[2] Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. ^[3] Division of Hematology in Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. ^[4] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States. ^[5]

关键词 DNA methylation marker MIBC ROC bladder cancer (BC)methylation and prognosis survival analysis

DOI 10.3389/fonc.2021.614927

PMID 33659216

发布时间 2022-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2021年11卷

614927页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除